DUPONT CAPITAL MANAGEMENT CORP - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$312,000
-6.0%
12,8910.0%0.02%
+15.4%
Q1 2022$332,000
-23.9%
12,891
-8.1%
0.01%
-18.8%
Q4 2021$436,000
-8.4%
14,032
-28.5%
0.02%
+6.7%
Q3 2021$476,000
+45.6%
19,627
-12.4%
0.02%
+87.5%
Q2 2021$327,000
-41.5%
22,4010.0%0.01%
-38.5%
Q1 2021$559,000
-24.0%
22,401
-17.0%
0.01%
-18.8%
Q4 2020$736,00026,9950.02%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,084,300$15,820,0003.32%
ARMISTICE CAPITAL, LLC 5,748,000$83,863,0001.50%
RA Capital Management 5,614,428$81,915,0001.32%
Krensavage Asset Management, LLC 140,000$2,043,0000.69%
CM Management, LLC 60,000$875,0000.63%
Altium Capital Management LP 170,484$2,487,0000.58%
HighVista Strategies LLC 53,498$781,0000.55%
Sio Capital Management, LLC 150,000$2,189,0000.54%
MANGROVE PARTNERS IM, LLC 295,037$4,305,0000.44%
Rock Springs Capital Management LP 1,494,164$21,800,0000.43%
View complete list of TRAVERE THERAPEUTICS INC shareholders